Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Revenue Quarterly
0
200M
400M
600M
Q3 '21: 471.4M
Q4 '21: 480.2M
Q1 '22: 482.1M
Q2 '22: 501M
Q3 '22: 521.3M
Q4 '22: 496.2M
Q1 '23: 467.2M
Q2 '23: 467.2M
Q3 '23: 404.6M
Q4 '23: 322.7M
Q1 '24: 302M
Q2 '24: 319.8M
Q3 '24: 350.1M
Q4 '24: 339.3M
Q1 '25: 332.1M
Q2 '25: 366.2M
Q3 '25: 392.2M
Q4 '25: 391.6M
Q1 '26: 405.5M
Q2 '26: 445.5M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit Quarterly
0
80M
160M
240M
Q3 '21: 181.2M
Q4 '21: 190.7M
Q1 '22: 196.7M
Q2 '22: 206.5M
Q3 '22: 217.8M
Q4 '22: 206.2M
Q1 '23: 194.5M
Q2 '23: 195.4M
Q3 '23: 155.9M
Q4 '23: 112.5M
Q1 '24: 99.6M
Q2 '24: 107.4M
Q3 '24: 118M
Q4 '24: 110.9M
Q1 '25: 104.7M
Q2 '25: 115.3M
Q3 '25: 120.5M
Q4 '25: 121.9M
Q1 '26: 128.8M
Q2 '26: 147.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Income Quarterly
0
40M
80M
120M
Q3 '21: 77.2M
Q4 '21: 86M
Q1 '22: 93.1M
Q2 '22: 106.2M
Q3 '22: 112.4M
Q4 '22: 96.5M
Q1 '23: 86.4M
Q2 '23: 89.6M
Q3 '23: 53.9M
Q4 '23: 20.7M
Q1 '24: 12.9M
Q2 '24: 3.7M
Q3 '24: 21.9M
Q4 '24: 11.9M
Q1 '25: 1.3M
Q2 '25: 9.4M
Q3 '25: 11.6M
Q4 '25: 13.2M
Q1 '26: 19.8M
Q2 '26: 33.3M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-35M
0
35M
70M
105M
Q3 '21: 68.4M
Q4 '21: 65.5M
Q1 '22: 72.7M
Q2 '22: 80.2M
Q3 '22: 86.4M
Q4 '22: 92.1M
Q1 '23: 71.2M
Q2 '23: 82M
Q3 '23: 48.7M
Q4 '23: 25.3M
Q1 '24: 14M
Q2 '24: 8M
Q3 '24: 13.7M
Q4 '24: 8.2M
Q1 '25: -4.4M
Q2 '25: 46.1M
Q3 '25: 14.3M
Q4 '25: 10.2M
Q1 '26: 15M
Q2 '26: 46.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Cost of Revenue Quarterly
0
150M
300M
450M
Q3 '21: 290.2M
Q4 '21: 289.5M
Q1 '22: 285.4M
Q2 '22: 294.4M
Q3 '22: 303.5M
Q4 '22: 290M
Q1 '23: 272.8M
Q2 '23: 271.8M
Q3 '23: 248.8M
Q4 '23: 210.2M
Q1 '24: 202.4M
Q2 '24: 212.4M
Q3 '24: 232.1M
Q4 '24: 228.4M
Q1 '25: 227.4M
Q2 '25: 250.9M
Q3 '25: 271.7M
Q4 '25: 269.6M
Q1 '26: 276.7M
Q2 '26: 298M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-50M
0
50M
100M
150M
Q3 '21: 98.9M
Q4 '21: 77.6M
Q1 '22: 72.3M
Q2 '22: 85M
Q3 '22: 132.2M
Q4 '22: 102.9M
Q1 '23: 99.8M
Q2 '23: 92.6M
Q3 '23: 50.1M
Q4 '23: 38.4M
Q1 '24: -31.1M
Q2 '24: 14.4M
Q3 '24: 54.4M
Q4 '24: 81.8M
Q1 '25: 56.7M
Q2 '25: 41.5M
Q3 '25: 79.1M
Q4 '25: 38.1M
Q1 '26: 64.3M
Q2 '26: 68.5M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-75M
-50M
-25M
0
25M
50M
75M
Q3 '21: 57.8M
Q4 '21: 22.5M
Q1 '22: 33.8M
Q2 '22: 45.5M
Q3 '22: 62.4M
Q4 '22: 39.1M
Q1 '23: 51.8M
Q2 '23: 55.6M
Q3 '23: 11.6M
Q4 '23: 11.1M
Q1 '24: -51.5M
Q2 '24: -3.5M
Q3 '24: 39.4M
Q4 '24: 62.1M
Q1 '25: 40.8M
Q2 '25: 21.1M
Q3 '25: 62.8M
Q4 '25: 12.4M
Q1 '26: 32.4M
Q2 '26: 34.8M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
20M
40M
60M
Q1 '20: 52.4M
Q2 '20: 52.6M
Q3 '20: 52.7M
Q1 '21: 45.2M
Q2 '21: 45.4M
Q3 '21: 45.6M
Q1 '22: 45.8M
Q2 '22: 45.8M
Q3 '22: 46M
Q1 '23: 46.2M
Q2 '23: 46.2M
Q3 '23: 46.3M
Q1 '24: 46.3M
Q2 '24: 46.3M
Q3 '24: 46.4M
Q1 '25: 46.4M
Q2 '25: 46.5M
Q3 '25: 46.4M
Q1 '26: 46.1M
Q2 '26: 46.4M
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
0.00
2.50
5.00
7.50
Q3 '21: 4.18
Q4 '21: 5.00
Q1 '22: 5.72
Q2 '22: 6.25
Q3 '22: 6.63
Q4 '22: 7.21
Q1 '23: 7.16
Q2 '23: 7.18
Q3 '23: 6.35
Q4 '23: 4.91
Q1 '24: 3.67
Q2 '24: 2.07
Q3 '24: 1.32
Q4 '24: 0.95
Q1 '25: 0.55
Q2 '25: 1.37
Q3 '25: 1.38
Q4 '25: 1.43
Q1 '26: 1.85
Q2 '26: 1.86
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.